Startseite Medizin National survey on appropriateness of clinical biochemistry reporting in China
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

National survey on appropriateness of clinical biochemistry reporting in China

  • Fengfeng Kang , Wei Wang und Zhiguo Wang EMAIL logo
Veröffentlicht/Copyright: 3. April 2015

Abstract

Background: Accurate and reliable testing reports play an important role in the prevention, diagnosis, treatment and prognosis of disease. However, little is known about the appropriateness of laboratory testing reporting in China. This national survey takes clinical biochemistry as an example to investigate the state of reporting appropriateness in our country.

Methods: An electronic questionnaire was sent to 1209 laboratories. The participants were asked to retrospectively evaluate the error rates of the following quality indicators: report template integrity, report content filling integrity, report delay, report recall, non-conformities between instrument and laboratory information system (LIS) data, non-conformities between report and request, report notification error, and report modification. Mann-Whitney and Kruskal-Wallis tests were used to identify the potential impacts of reporting appropriateness.

Results: A total of 662 of the 1209 laboratories (55%) submitted the survey results, with three returning incomplete data. For the integrity of the report, only 31% of the laboratories had a complete report template that contained all of 21 elements. In addition, the overall error rate of content filling integrity was 45.9% for 19,770 pieces of reports. The overall σ-values of other six quality indicators were all >4, and no significant difference was found among different departments. Group comparison suggested that reporting electronically had a better performance.

Conclusions: The laboratory reporting system in China needs to improve, particularly the integrity of the report. Strengthening information technology will not only promote reporting appropriateness, but also guarantee accurate, standardized and traceable data collection and long-term monitoring.


Corresponding author: Professor Zhiguo Wang, National Center for Clinical Laboratories, Beijing Hospital, No. 1, Dahua Road, Dongdan, Dongcheng District, Beijing 100730, P.R. China, Phone: +86 10 58115054, Fax: +86 10 65273025, E-mail:

References

1. Simundic AM, Bilic-Zulle L, Nikolac N, Supak-Smolcic V, Honovic L, Avram S, et al. The quality of the extra-analytical phase of laboratory practice in some developing European countries and Mexico – a multicentric study. Clin Chem Lab Med 2011;49:215–28.10.1515/CCLM.2011.034Suche in Google Scholar PubMed

2. Lippi G, Fostini R, Guidi GC. Quality improvement in laboratory medicine: extra-analytical issues. Clin Lab Med 2008;28:285–94.10.1016/j.cll.2007.12.007Suche in Google Scholar PubMed

3. Laposata M, Dighe A. “Pre-pre” and “post-post” analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 2007;45:712–9.10.1515/CCLM.2007.173Suche in Google Scholar PubMed

4. ISO 15189:2012. Medical laboratories – Requirements for quality and competence, 3rd ed. Geneva, Switzerland: International Organization for Standards, 2012.Suche in Google Scholar

5. Plebani M, Sciacovelli L, Marinova M, Marcuccitti J, Chiozza ML. Quality indicators in laboratory medicine: a fundamental tool for quality and patient safety. Clin Biochem 2013;46:1170–4.10.1016/j.clinbiochem.2012.11.028Suche in Google Scholar PubMed

6. Sciacovelli L, Zardo L, Secchiero S, Plebani M. Quality specifications in EQA schemes: from theory to practice. Clin Chim Acta 2004;346:87–97.10.1016/j.cccn.2004.02.037Suche in Google Scholar PubMed

7. Plebani M, Astion ML, Barth JH, Chen W, de Oliveira Galoro CA, Escuer MI, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med 2014;52:951–8.Suche in Google Scholar

8. RCLMO. Regulation on clinical laboratory in medical organization. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2006.Suche in Google Scholar

9. Barth JH. Clinical quality indicators in laboratory medicine. Ann Clin Biochem 2012;49:9–16.10.1258/acb.2011.011126Suche in Google Scholar PubMed

10. Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem 2010;47:101–10.10.1258/acb.2009.009222Suche in Google Scholar PubMed

11. Zeng R, Wang W, Wang ZG. National survey on critical values notification of 599 institutions in China. Clin Chem Lab Med 2013;51:2099–107.10.1515/cclm-2013-0183Suche in Google Scholar PubMed

12. Plebani M, Chiozza ML, Sciacovelli L. Towards harmonization of quality indicators in laboratory medicine. Clin Chem Lab Med 2013;51:187–95.10.1515/cclm-2012-0582Suche in Google Scholar PubMed

13. Sciacovelli L, O’Kane M, Skaik YA, Caciagli P, Pellegrini C, Da Rin G, et al. Quality indicators in laboratory medicine: from theory to practice. Preliminary data from the IFCC Working Group Project “Laboratory Errors and Patient Safety”. Clin Chem Lab Med 2011;49:835–44.Suche in Google Scholar

14. Nevalainen D, Berte L, Kraft C, Leigh E, Picaso L, Morgan T. Evaluating laboratory performance on quality indicators with the six sigma scale. Arch Pathol Lab Med 2000;124:516–9.10.5858/2000-124-0516-ELPOQISuche in Google Scholar PubMed

15. Harry MJ. Six Sigma: a breakthrough strategy for profitability. Qual Prog 1998;31:60–4.Suche in Google Scholar

16. Westgard JO. The six sigma calculators. Available from: http://www.westgard.com/six-sigma-calculators-2.htm. Accessed 3 February, 2015.Suche in Google Scholar

Received: 2014-12-22
Accepted: 2015-3-3
Published Online: 2015-4-3
Published in Print: 2015-10-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it
  4. The standardization of the urine albumin assays: no longer deferrable
  5. Reviews
  6. The role of telomeres and vitamin D in cellular aging and age-related diseases
  7. Atypical hemolytic uremic syndrome: from diagnosis to treatment
  8. Clinical relevance and contemporary methods for counting blood cells in body fluids suspected of inflammatory disease
  9. EFLM Opinion Paper
  10. How to assess the quality of your analytical method?
  11. Genetics and Molecular Diagnostics
  12. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay
  13. General Clinical Chemistry and Laboratory Medicine
  14. Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data
  15. A study examining the bias of albumin and albumin/creatinine ratio measurements in urine
  16. National survey on appropriateness of clinical biochemistry reporting in China
  17. Potentiometric measurement of urinary iodine concentration in patients with thyroid diseases with and without previous exposure to non-radioactive iodine
  18. Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program
  19. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis
  20. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies
  21. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty
  22. Whole blood thromboelastometry profiles in women with preeclampsia
  23. Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis
  24. Reference Values and Biological Variations
  25. Reference ranges of serum bile acids in children and adolescents
  26. Infectious Diseases
  27. Elevated circulating ghrelin, but not peptide YY(3-36) levels, in term neonates with infection
  28. Cardiovascular Diseases
  29. Head-to-head comparison of 10 natriuretic peptide assays
  30. Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors
  31. Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death
  32. Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins
  33. A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population
  34. Letter to the Editors
  35. Laboratory medicine: let’s say it is the mirror of science (and medicine)
  36. The economic burden of hemolysis
  37. Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins
  38. Cuvette carryover with the gentamicin assay on the Beckman AU480 analyser
  39. Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases
  40. Automated alkaline-pH electrophoresis followed by densitometry does not correlate with cation-exchange (CE)-HPLC in quantification of HbA2 and variant hemoglobins
  41. Progression from light chain myeloma to secondary plasma cell leukemia accompanied by peripheral blood eosinophilia
  42. Harmonization of results has not been fully achieved for serum immunoglobulin measurements
  43. The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  44. Comparison of nucleated red blood cell count with four commercial hematological analyzers
  45. Reply to: The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  46. Congress Abstracts
  47. Congress of Clinical Chemistry and Laboratory Medicine
  48. 47th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  49. 15th EFLM Continuous Postgraduate Course in Clinical Chemistry and Laboratory Medicine
Heruntergeladen am 22.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0127/html?lang=de
Button zum nach oben scrollen